Sleep Disorder Therapies Market - Global Outlook and Forecast 2022-2028

March 2022 | 63 pages | ID: S199A7273053EN
Market Monitor Global

Abstracts

Sleep disorders involve problems with the quality, timing and amount of sleep, which cause problems with functioning and distress during the daytime.

This report contains market size and forecasts of Sleep Disorder Therapies in Global, including the following market information:

Global Sleep Disorder Therapies Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Sleep Disorder Therapies market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Insomnia Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Sleep Disorder Therapies include Sanofi, Phillips Healthcare, Nox Medical, Fisher and Paykel Healthcare, Responsive Surface Technology, Eight Sleep, Sleep Number, Vanda Pharmaceuticals and Eli Lilly, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Sleep Disorder Therapies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Sleep Disorder Therapies Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Sleep Disorder Therapies Market Segment Percentages, by Type, 2021 (%)

• Insomnia
• Excessive Sleep
• Disturbed Sleep

Global Sleep Disorder Therapies Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Sleep Disorder Therapies Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies

Global Sleep Disorder Therapies Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Sleep Disorder Therapies Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Sleep Disorder Therapies revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Sleep Disorder Therapies revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Sanofi
• Phillips Healthcare
• Nox Medical
• Fisher and Paykel Healthcare
• Responsive Surface Technology
• Eight Sleep
• Sleep Number
• Vanda Pharmaceuticals
• Eli Lilly
• Neurim Pharmaceuticals
• Merck

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Sleep Disorder Therapies Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Sleep Disorder Therapies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL SLEEP DISORDER THERAPIES OVERALL MARKET SIZE

2.1 Global Sleep Disorder Therapies Market Size: 2021 VS 2028
2.2 Global Sleep Disorder Therapies Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Sleep Disorder Therapies Players in Global Market
3.2 Top Global Sleep Disorder Therapies Companies Ranked by Revenue
3.3 Global Sleep Disorder Therapies Revenue by Companies
3.4 Top 3 and Top 5 Sleep Disorder Therapies Companies in Global Market, by Revenue in 2021
3.5 Global Companies Sleep Disorder Therapies Product Type
3.6 Tier 1, Tier 2 and Tier 3 Sleep Disorder Therapies Players in Global Market
  3.6.1 List of Global Tier 1 Sleep Disorder Therapies Companies
  3.6.2 List of Global Tier 2 and Tier 3 Sleep Disorder Therapies Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Sleep Disorder Therapies Market Size Markets, 2021 & 2028
  4.1.2 Insomnia
  4.1.3 Excessive Sleep
  4.1.4 Disturbed Sleep
4.2 By Type - Global Sleep Disorder Therapies Revenue & Forecasts
  4.2.1 By Type - Global Sleep Disorder Therapies Revenue, 2017-2022
  4.2.2 By Type - Global Sleep Disorder Therapies Revenue, 2023-2028
  4.2.3 By Type - Global Sleep Disorder Therapies Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Sleep Disorder Therapies Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Online Pharmacies
  5.1.4 Retail Pharmacies
5.2 By Application - Global Sleep Disorder Therapies Revenue & Forecasts
  5.2.1 By Application - Global Sleep Disorder Therapies Revenue, 2017-2022
  5.2.2 By Application - Global Sleep Disorder Therapies Revenue, 2023-2028
  5.2.3 By Application - Global Sleep Disorder Therapies Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Sleep Disorder Therapies Market Size, 2021 & 2028
6.2 By Region - Global Sleep Disorder Therapies Revenue & Forecasts
  6.2.1 By Region - Global Sleep Disorder Therapies Revenue, 2017-2022
  6.2.2 By Region - Global Sleep Disorder Therapies Revenue, 2023-2028
  6.2.3 By Region - Global Sleep Disorder Therapies Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Sleep Disorder Therapies Revenue, 2017-2028
  6.3.2 US Sleep Disorder Therapies Market Size, 2017-2028
  6.3.3 Canada Sleep Disorder Therapies Market Size, 2017-2028
  6.3.4 Mexico Sleep Disorder Therapies Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Sleep Disorder Therapies Revenue, 2017-2028
  6.4.2 Germany Sleep Disorder Therapies Market Size, 2017-2028
  6.4.3 France Sleep Disorder Therapies Market Size, 2017-2028
  6.4.4 U.K. Sleep Disorder Therapies Market Size, 2017-2028
  6.4.5 Italy Sleep Disorder Therapies Market Size, 2017-2028
  6.4.6 Russia Sleep Disorder Therapies Market Size, 2017-2028
  6.4.7 Nordic Countries Sleep Disorder Therapies Market Size, 2017-2028
  6.4.8 Benelux Sleep Disorder Therapies Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Sleep Disorder Therapies Revenue, 2017-2028
  6.5.2 China Sleep Disorder Therapies Market Size, 2017-2028
  6.5.3 Japan Sleep Disorder Therapies Market Size, 2017-2028
  6.5.4 South Korea Sleep Disorder Therapies Market Size, 2017-2028
  6.5.5 Southeast Asia Sleep Disorder Therapies Market Size, 2017-2028
  6.5.6 India Sleep Disorder Therapies Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Sleep Disorder Therapies Revenue, 2017-2028
  6.6.2 Brazil Sleep Disorder Therapies Market Size, 2017-2028
  6.6.3 Argentina Sleep Disorder Therapies Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Sleep Disorder Therapies Revenue, 2017-2028
  6.7.2 Turkey Sleep Disorder Therapies Market Size, 2017-2028
  6.7.3 Israel Sleep Disorder Therapies Market Size, 2017-2028
  6.7.4 Saudi Arabia Sleep Disorder Therapies Market Size, 2017-2028
  6.7.5 UAE Sleep Disorder Therapies Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Sanofi
  7.1.1 Sanofi Corporate Summary
  7.1.2 Sanofi Business Overview
  7.1.3 Sanofi Sleep Disorder Therapies Major Product Offerings
  7.1.4 Sanofi Sleep Disorder Therapies Revenue in Global Market (2017-2022)
  7.1.5 Sanofi Key News
7.2 Phillips Healthcare
  7.2.1 Phillips Healthcare Corporate Summary
  7.2.2 Phillips Healthcare Business Overview
  7.2.3 Phillips Healthcare Sleep Disorder Therapies Major Product Offerings
  7.2.4 Phillips Healthcare Sleep Disorder Therapies Revenue in Global Market (2017-2022)
  7.2.5 Phillips Healthcare Key News
7.3 Nox Medical
  7.3.1 Nox Medical Corporate Summary
  7.3.2 Nox Medical Business Overview
  7.3.3 Nox Medical Sleep Disorder Therapies Major Product Offerings
  7.3.4 Nox Medical Sleep Disorder Therapies Revenue in Global Market (2017-2022)
  7.3.5 Nox Medical Key News
7.4 Fisher and Paykel Healthcare
  7.4.1 Fisher and Paykel Healthcare Corporate Summary
  7.4.2 Fisher and Paykel Healthcare Business Overview
  7.4.3 Fisher and Paykel Healthcare Sleep Disorder Therapies Major Product Offerings
  7.4.4 Fisher and Paykel Healthcare Sleep Disorder Therapies Revenue in Global Market (2017-2022)
  7.4.5 Fisher and Paykel Healthcare Key News
7.5 Responsive Surface Technology
  7.5.1 Responsive Surface Technology Corporate Summary
  7.5.2 Responsive Surface Technology Business Overview
  7.5.3 Responsive Surface Technology Sleep Disorder Therapies Major Product Offerings
  7.5.4 Responsive Surface Technology Sleep Disorder Therapies Revenue in Global Market (2017-2022)
  7.5.5 Responsive Surface Technology Key News
7.6 Eight Sleep
  7.6.1 Eight Sleep Corporate Summary
  7.6.2 Eight Sleep Business Overview
  7.6.3 Eight Sleep Sleep Disorder Therapies Major Product Offerings
  7.6.4 Eight Sleep Sleep Disorder Therapies Revenue in Global Market (2017-2022)
  7.6.5 Eight Sleep Key News
7.7 Sleep Number
  7.7.1 Sleep Number Corporate Summary
  7.7.2 Sleep Number Business Overview
  7.7.3 Sleep Number Sleep Disorder Therapies Major Product Offerings
  7.7.4 Sleep Number Sleep Disorder Therapies Revenue in Global Market (2017-2022)
  7.7.5 Sleep Number Key News
7.8 Vanda Pharmaceuticals
  7.8.1 Vanda Pharmaceuticals Corporate Summary
  7.8.2 Vanda Pharmaceuticals Business Overview
  7.8.3 Vanda Pharmaceuticals Sleep Disorder Therapies Major Product Offerings
  7.8.4 Vanda Pharmaceuticals Sleep Disorder Therapies Revenue in Global Market (2017-2022)
  7.8.5 Vanda Pharmaceuticals Key News
7.9 Eli Lilly
  7.9.1 Eli Lilly Corporate Summary
  7.9.2 Eli Lilly Business Overview
  7.9.3 Eli Lilly Sleep Disorder Therapies Major Product Offerings
  7.9.4 Eli Lilly Sleep Disorder Therapies Revenue in Global Market (2017-2022)
  7.9.5 Eli Lilly Key News
7.10 Neurim Pharmaceuticals
  7.10.1 Neurim Pharmaceuticals Corporate Summary
  7.10.2 Neurim Pharmaceuticals Business Overview
  7.10.3 Neurim Pharmaceuticals Sleep Disorder Therapies Major Product Offerings
  7.10.4 Neurim Pharmaceuticals Sleep Disorder Therapies Revenue in Global Market (2017-2022)
  7.10.5 Neurim Pharmaceuticals Key News
7.11 Merck
  7.11.1 Merck Corporate Summary
  7.11.2 Merck Business Overview
  7.11.3 Merck Sleep Disorder Therapies Major Product Offerings
  7.11.4 Merck Sleep Disorder Therapies Revenue in Global Market (2017-2022)
  7.11.5 Merck Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Sleep Disorder Therapies Market Opportunities & Trends in Global Market
Table 2. Sleep Disorder Therapies Market Drivers in Global Market
Table 3. Sleep Disorder Therapies Market Restraints in Global Market
Table 4. Key Players of Sleep Disorder Therapies in Global Market
Table 5. Top Sleep Disorder Therapies Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Sleep Disorder Therapies Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Sleep Disorder Therapies Revenue Share by Companies, 2017-2022
Table 8. Global Companies Sleep Disorder Therapies Product Type
Table 9. List of Global Tier 1 Sleep Disorder Therapies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Sleep Disorder Therapies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Sleep Disorder Therapies Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Sleep Disorder Therapies Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Sleep Disorder Therapies Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Sleep Disorder Therapies Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Sleep Disorder Therapies Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Sleep Disorder Therapies Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Sleep Disorder Therapies Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Sleep Disorder Therapies Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Sleep Disorder Therapies Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Sleep Disorder Therapies Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Sleep Disorder Therapies Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Sleep Disorder Therapies Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Sleep Disorder Therapies Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Sleep Disorder Therapies Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Sleep Disorder Therapies Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Sleep Disorder Therapies Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Sleep Disorder Therapies Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Sleep Disorder Therapies Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Sleep Disorder Therapies Revenue, (US$, Mn), 2023-2028
Table 30. Sanofi Corporate Summary
Table 31. Sanofi Sleep Disorder Therapies Product Offerings
Table 32. Sanofi Sleep Disorder Therapies Revenue (US$, Mn), (2017-2022)
Table 33. Phillips Healthcare Corporate Summary
Table 34. Phillips Healthcare Sleep Disorder Therapies Product Offerings
Table 35. Phillips Healthcare Sleep Disorder Therapies Revenue (US$, Mn), (2017-2022)
Table 36. Nox Medical Corporate Summary
Table 37. Nox Medical Sleep Disorder Therapies Product Offerings
Table 38. Nox Medical Sleep Disorder Therapies Revenue (US$, Mn), (2017-2022)
Table 39. Fisher and Paykel Healthcare Corporate Summary
Table 40. Fisher and Paykel Healthcare Sleep Disorder Therapies Product Offerings
Table 41. Fisher and Paykel Healthcare Sleep Disorder Therapies Revenue (US$, Mn), (2017-2022)
Table 42. Responsive Surface Technology Corporate Summary
Table 43. Responsive Surface Technology Sleep Disorder Therapies Product Offerings
Table 44. Responsive Surface Technology Sleep Disorder Therapies Revenue (US$, Mn), (2017-2022)
Table 45. Eight Sleep Corporate Summary
Table 46. Eight Sleep Sleep Disorder Therapies Product Offerings
Table 47. Eight Sleep Sleep Disorder Therapies Revenue (US$, Mn), (2017-2022)
Table 48. Sleep Number Corporate Summary
Table 49. Sleep Number Sleep Disorder Therapies Product Offerings
Table 50. Sleep Number Sleep Disorder Therapies Revenue (US$, Mn), (2017-2022)
Table 51. Vanda Pharmaceuticals Corporate Summary
Table 52. Vanda Pharmaceuticals Sleep Disorder Therapies Product Offerings
Table 53. Vanda Pharmaceuticals Sleep Disorder Therapies Revenue (US$, Mn), (2017-2022)
Table 54. Eli Lilly Corporate Summary
Table 55. Eli Lilly Sleep Disorder Therapies Product Offerings
Table 56. Eli Lilly Sleep Disorder Therapies Revenue (US$, Mn), (2017-2022)
Table 57. Neurim Pharmaceuticals Corporate Summary
Table 58. Neurim Pharmaceuticals Sleep Disorder Therapies Product Offerings
Table 59. Neurim Pharmaceuticals Sleep Disorder Therapies Revenue (US$, Mn), (2017-2022)
Table 60. Merck Corporate Summary
Table 61. Merck Sleep Disorder Therapies Product Offerings
Table 62. Merck Sleep Disorder Therapies Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Sleep Disorder Therapies Segment by Type in 2021
Figure 2. Sleep Disorder Therapies Segment by Application in 2021
Figure 3. Global Sleep Disorder Therapies Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Sleep Disorder Therapies Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Sleep Disorder Therapies Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Sleep Disorder Therapies Revenue in 2021
Figure 8. By Type - Global Sleep Disorder Therapies Revenue Market Share, 2017-2028
Figure 9. By Application - Global Sleep Disorder Therapies Revenue Market Share, 2017-2028
Figure 10. By Region - Global Sleep Disorder Therapies Revenue Market Share, 2017-2028
Figure 11. By Country - North America Sleep Disorder Therapies Revenue Market Share, 2017-2028
Figure 12. US Sleep Disorder Therapies Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Sleep Disorder Therapies Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Sleep Disorder Therapies Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Sleep Disorder Therapies Revenue Market Share, 2017-2028
Figure 16. Germany Sleep Disorder Therapies Revenue, (US$, Mn), 2017-2028
Figure 17. France Sleep Disorder Therapies Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Sleep Disorder Therapies Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Sleep Disorder Therapies Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Sleep Disorder Therapies Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Sleep Disorder Therapies Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Sleep Disorder Therapies Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Sleep Disorder Therapies Revenue Market Share, 2017-2028
Figure 24. China Sleep Disorder Therapies Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Sleep Disorder Therapies Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Sleep Disorder Therapies Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Sleep Disorder Therapies Revenue, (US$, Mn), 2017-2028
Figure 28. India Sleep Disorder Therapies Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Sleep Disorder Therapies Revenue Market Share, 2017-2028
Figure 30. Brazil Sleep Disorder Therapies Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Sleep Disorder Therapies Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Sleep Disorder Therapies Revenue Market Share, 2017-2028
Figure 33. Turkey Sleep Disorder Therapies Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Sleep Disorder Therapies Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Sleep Disorder Therapies Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Sleep Disorder Therapies Revenue, (US$, Mn), 2017-2028
Figure 37. Sanofi Sleep Disorder Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Phillips Healthcare Sleep Disorder Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Nox Medical Sleep Disorder Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Fisher and Paykel Healthcare Sleep Disorder Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Responsive Surface Technology Sleep Disorder Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Eight Sleep Sleep Disorder Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sleep Number Sleep Disorder Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Vanda Pharmaceuticals Sleep Disorder Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Eli Lilly Sleep Disorder Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Neurim Pharmaceuticals Sleep Disorder Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Merck Sleep Disorder Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)